Simulations Plus (SLP) and University of Connecticut Announce FDA Contract to Accelerate Development of Long-Acting Injectable Products

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Simulations Plus (SLP) and University of Connecticut Announce FDA Contract to Accelerate Development of Long-Acting Injectable Products

Simulations Plus (SLP) Misses Q4 EPS by 4c

October 25, 2021 4:10 PM EDT

Simulations Plus (NASDAQ: SLP) reported Q4 EPS of $0.01, $0.04 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $9.8 million versus the consensus estimate of $8.17 million.

GUIDANCE:

Simulations Plus sees FY2022 revenue of $51-53 million, versus the consensus of... More